621 related articles for article (PubMed ID: 27544072)
1. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
[TBL] [Abstract][Full Text] [Related]
2. Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation.
Imran A; Tariq Shehzad M; Al Adhami T; Miraz Rahman K; Hussain D; Alharthy RD; Shafiq Z; Iqbal J
Bioorg Chem; 2021 Oct; 115():105164. PubMed ID: 34314916
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular modeling, selective aldose reductase inhibition and hypoglycemic activity of novel meglitinides.
Salem MG; Abdel Aziz YM; Elewa M; Nafie MS; Elshihawy HA; Said MM
Bioorg Chem; 2021 Jun; 111():104909. PubMed ID: 33895603
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of selective hybrid coumarin-thiazolidinedione aldose reductase-II inhibitors as potential antidiabetics.
Kumar Pasala V; Gudipudi G; Sankeshi V; Basude M; Gundla R; Singh Jadav S; Srinivas B; Yadaiah Goud E; Nareshkumar D
Bioorg Chem; 2021 Sep; 114():104970. PubMed ID: 34120026
[TBL] [Abstract][Full Text] [Related]
5. Substituted 2-thioxothiazolidin-4-one derivatives showed protective effects against diabetic cataract via inhibition of aldose reductase.
Huang W; Zhang Y; Liang X; Yang L
Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900371. PubMed ID: 32237167
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
[TBL] [Abstract][Full Text] [Related]
7. Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition.
Javid N; Munir R; Chaudhry F; Imran A; Zaib S; Muzaffar A; Iqbal J
Bioorg Chem; 2020 Jun; 99():103852. PubMed ID: 32325339
[TBL] [Abstract][Full Text] [Related]
8. (5-Hydroxy-4-oxo-2-styryl-4
Chen H; Zhang X; Zhang X; Liu W; Lei Y; Zhu C; Ma B
Molecules; 2020 Nov; 25(21):. PubMed ID: 33158254
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones.
Qin X; Hao X; Han H; Zhu S; Yang Y; Wu B; Hussain S; Parveen S; Jing C; Ma B; Zhu C
J Med Chem; 2015 Feb; 58(3):1254-67. PubMed ID: 25602762
[TBL] [Abstract][Full Text] [Related]
10. Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study.
Shehzad MT; Imran A; Njateng GSS; Hameed A; Islam M; Al-Rashida M; Uroos M; Asari A; Shafiq Z; Iqbal J
Bioorg Chem; 2019 Jun; 87():857-866. PubMed ID: 30551808
[TBL] [Abstract][Full Text] [Related]
11. Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
Mohd Siddique MU; Thakur A; Shilkar D; Yasmin S; Halakova D; Kovacikova L; Prnova MS; Stefek M; Acevedo O; Dasararaju G; Devadasan V; Mondal SK; Jayaprakash V
Eur J Med Chem; 2021 Nov; 223():113630. PubMed ID: 34175538
[TBL] [Abstract][Full Text] [Related]
12. 6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
Kato A; Kobayashi K; Narukawa K; Minoshima Y; Adachi I; Hirono S; Nash RJ
Bioorg Med Chem Lett; 2010 Oct; 20(19):5630-3. PubMed ID: 20805028
[TBL] [Abstract][Full Text] [Related]
13. Exploring antidiabetic potential of adamantyl-thiosemicarbazones via aldose reductase (ALR2) inhibition.
Shehzad MT; Hameed A; Al-Rashida M; Imran A; Uroos M; Asari A; Mohamad H; Islam M; Iftikhar S; Shafiq Z; Iqbal J
Bioorg Chem; 2019 Nov; 92():103244. PubMed ID: 31541804
[TBL] [Abstract][Full Text] [Related]
14. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
Rastelli G; Ferrari AM; Costantino L; Gamberini MC
Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
[TBL] [Abstract][Full Text] [Related]
15. Novel substituted N-benzyl(oxotriazinoindole) inhibitors of aldose reductase exploiting ALR2 unoccupied interactive pocket.
Hlaváč M; Kováčiková L; Šoltésová Prnová M; Addová G; Hanquet G; Štefek M; Boháč A
Bioorg Med Chem; 2021 Jan; 29():115885. PubMed ID: 33271452
[TBL] [Abstract][Full Text] [Related]
16. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
17. Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
Carbone V; Zhao HT; Chung R; Endo S; Hara A; El-Kabbani O
Bioorg Med Chem; 2009 Feb; 17(3):1244-50. PubMed ID: 19121944
[TBL] [Abstract][Full Text] [Related]
18. Exploration of thioxothiazolidinone-sulfonate conjugates as a new class of aldehyde/aldose reductase inhibitors: A synthetic and computational investigation.
Andleeb H; Tehseen Y; Jabeen F; Khan I; Iqbal J; Hameed S
Bioorg Chem; 2017 Dec; 75():1-15. PubMed ID: 28888096
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of chiral 2H-chromene-N-imidazolo-amino acid conjugates as aldose reductase inhibitors.
Gopinath G; Sankeshi V; Perugu S; Alaparthi MD; Bandaru S; Pasala VK; Chittineni PR; Krupadanam GLD; Sagurthi SR
Eur J Med Chem; 2016 Nov; 124():750-762. PubMed ID: 27639366
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, molecular docking studies of coumarinyl-pyrazolinyl substituted thiazoles as non-competitive inhibitors of mushroom tyrosinase.
Saeed A; Mahesar PA; Channar PA; Abbas Q; Larik FA; Hassan M; Raza H; Seo SY
Bioorg Chem; 2017 Oct; 74():187-196. PubMed ID: 28837887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
